Colgate-Palmolive Company
Colgate-Palmolive Company (0P59.L) Financial Performance & Income Statement Overview
Analyze Colgate-Palmolive Company (0P59.L) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Colgate-Palmolive Company (0P59.L) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Colgate-Palmolive Company 0P59.L financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $4.91B | $4.95B | $5.03B | $5.06B |
| Cost of Revenue | $1.92B | $1.96B | $1.96B | $1.99B |
| Gross Profit | $2.99B | $2.98B | $3.07B | $3.07B |
| Gross Profit Ratio | $0.61 | $0.60 | $0.61 | $0.61 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.90B | $1.90B | $1.98B | $1.91B |
| Operating Expenses | $1.91B | $1.92B | $2.009B | $1.91B |
| Total Costs & Expenses | $3.82B | $3.88B | $3.97B | $3.90B |
| Interest Income | $15.00M | $68.00M | $0.00 | $0.00 |
| Interest Expense | $66.00M | $118.00M | $56.00M | $60.00M |
| Depreciation & Amortization | $57.00M | $148.00M | $150.00M | $157.00M |
| EBITDA | $1.17B | $1.19B | $1.22B | $1.25B |
| EBITDA Ratio | $0.24 | $0.24 | $0.24 | $0.25 |
| Operating Income | $1.08B | $1.06B | $1.06B | $1.16B |
| Operating Income Ratio | $0.22 | $0.21 | $0.21 | $0.23 |
| Other Income/Expenses (Net) | -$123.00M | -$70.00M | -$79.00M | -$82.00M |
| Income Before Tax | $953.00M | $993.00M | $986.00M | $1.01B |
| Income Before Tax Ratio | $0.19 | $0.20 | $0.20 | $0.20 |
| Income Tax Expense | $227.00M | $214.00M | $210.00M | $243.00M |
| Net Income | $690.00M | $739.00M | $737.00M | $731.00M |
| Net Income Ratio | $0.14 | $0.15 | $0.15 | $0.14 |
| EPS | $0.85 | $0.90 | $0.90 | $0.89 |
| Diluted EPS | $0.85 | $0.90 | $0.90 | $0.89 |
| Weighted Avg Shares Outstanding | $817.70M | $817.70M | $817.70M | $819.70M |
| Weighted Avg Shares Outstanding (Diluted) | $822.50M | $822.50M | $822.50M | $823.70M |
Over the last four quarters, Colgate-Palmolive Company's revenue moved from $5.06B in Q2 2024 to $4.91B in Q1 2025. Operating income in Q1 2025 was $1.08B, with a strong operating margin of 22%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Colgate-Palmolive Company remained robust at $1.17B, reflecting operational efficiency. Net income dropped to $690.00M, with an EPS of $0.85. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan